Its small molecular size
Removing it reduces IGFBP affinity by approximately 90%, increasing the free fraction of the peptide available for IGF1R engagement
Philippine data report a rate of 12.2% with important co-morbidities such as obesity (56%) and diabetes mellitus (69%)
It has been widely used in anti-aging and cosmetic products for decades without any adverse effects, and can be easily incorporated into creams, liposomes, foams, or subcutaneous injections
27:479-488 (2018) Hara KY, Kiriyama K, Inagaki A, Nakayama H, Kondo A
The decision about treatment duration should be made collaboratively between patient and physician, considering individual response, tolerability, cost, insurance coverage, and personal goals